nodes	percent_of_prediction	percent_of_DWPC	metapath
Thioridazine—CYP2D6—breast cancer	0.132	1	CbGaD
Thioridazine—HTR6—Raloxifene—breast cancer	0.0816	0.172	CbGbCtD
Thioridazine—Promazine—Tamoxifen—breast cancer	0.0736	1	CrCrCtD
Thioridazine—CYP1A2—Anastrozole—breast cancer	0.0341	0.0718	CbGbCtD
Thioridazine—CYP1A2—Toremifene—breast cancer	0.0312	0.0656	CbGbCtD
Thioridazine—CYP2C9—Anastrozole—breast cancer	0.0308	0.0647	CbGbCtD
Thioridazine—CYP2C8—Lapatinib—breast cancer	0.0294	0.0619	CbGbCtD
Thioridazine—CYP2C19—Lapatinib—breast cancer	0.0247	0.0519	CbGbCtD
Thioridazine—CYP2C9—Idarubicin—breast cancer	0.0233	0.049	CbGbCtD
Thioridazine—CYP2C8—Raloxifene—breast cancer	0.0223	0.0469	CbGbCtD
Thioridazine—CYP2D6—Idarubicin—breast cancer	0.0213	0.0448	CbGbCtD
Thioridazine—CYP2E1—Tamoxifen—breast cancer	0.0197	0.0415	CbGbCtD
Thioridazine—CYP2E1—Mitoxantrone—breast cancer	0.0192	0.0404	CbGbCtD
Thioridazine—CYP2C8—Tamoxifen—breast cancer	0.0147	0.031	CbGbCtD
Thioridazine—CYP2C9—Capecitabine—breast cancer	0.0128	0.0268	CbGbCtD
Thioridazine—CYP2C19—Tamoxifen—breast cancer	0.0124	0.026	CbGbCtD
Thioridazine—CYP2C8—Paclitaxel—breast cancer	0.0115	0.0241	CbGbCtD
Thioridazine—CYP1A2—Tamoxifen—breast cancer	0.0114	0.024	CbGbCtD
Thioridazine—CYP2C8—Fluorouracil—breast cancer	0.0109	0.0228	CbGbCtD
Thioridazine—CYP2D6—Vinorelbine—breast cancer	0.0104	0.0219	CbGbCtD
Thioridazine—CYP2C9—Tamoxifen—breast cancer	0.0103	0.0216	CbGbCtD
Thioridazine—CYP2D6—Tamoxifen—breast cancer	0.0094	0.0198	CbGbCtD
Thioridazine—CYP1A2—Fluorouracil—breast cancer	0.00841	0.0177	CbGbCtD
Thioridazine—CYP2C9—Paclitaxel—breast cancer	0.008	0.0168	CbGbCtD
Thioridazine—CYP2C9—Fluorouracil—breast cancer	0.00757	0.0159	CbGbCtD
Thioridazine—CYP2D6—Vinblastine—breast cancer	0.00642	0.0135	CbGbCtD
Thioridazine—CYP2D6—Doxorubicin—breast cancer	0.00394	0.00829	CbGbCtD
Thioridazine—Trifluoperazine—S100A4—breast cancer	0.000807	0.186	CrCbGaD
Thioridazine—CYP2C8—mammary gland—breast cancer	0.0005	0.0346	CbGeAlD
Thioridazine—KCNH2—nipple—breast cancer	0.000452	0.0313	CbGeAlD
Thioridazine—CYP2C9—mammary gland—breast cancer	0.000445	0.0308	CbGeAlD
Thioridazine—CYP1A2—nipple—breast cancer	0.000387	0.0268	CbGeAlD
Thioridazine—HRH1—nipple—breast cancer	0.000363	0.0251	CbGeAlD
Thioridazine—ADRA2A—nipple—breast cancer	0.000356	0.0247	CbGeAlD
Thioridazine—HTR7—epithelium—breast cancer	0.000327	0.0226	CbGeAlD
Thioridazine—ADRA1A—epithelium—breast cancer	0.000315	0.0218	CbGeAlD
Thioridazine—HTR2C—female reproductive system—breast cancer	0.000302	0.0209	CbGeAlD
Thioridazine—KCNH2—endometrium—breast cancer	0.000273	0.0189	CbGeAlD
Thioridazine—CHRM2—endocrine gland—breast cancer	0.000265	0.0184	CbGeAlD
Thioridazine—ADRA1A—adipose tissue—breast cancer	0.000255	0.0176	CbGeAlD
Thioridazine—KCNH2—uterus—breast cancer	0.000252	0.0174	CbGeAlD
Thioridazine—DRD2—pituitary gland—breast cancer	0.000251	0.0174	CbGeAlD
Thioridazine—CYP2C8—endometrium—breast cancer	0.00025	0.0173	CbGeAlD
Thioridazine—HTR2A—embryo—breast cancer	0.00025	0.0173	CbGeAlD
Thioridazine—HTR1A—adrenal gland—breast cancer	0.000248	0.0172	CbGeAlD
Thioridazine—KCNH2—pituitary gland—breast cancer	0.000247	0.0171	CbGeAlD
Thioridazine—HRH1—epithelium—breast cancer	0.000244	0.0169	CbGeAlD
Thioridazine—HTR7—female reproductive system—breast cancer	0.000243	0.0168	CbGeAlD
Thioridazine—HTR7—adrenal gland—breast cancer	0.000237	0.0164	CbGeAlD
Thioridazine—Encainide—CYP2D6—breast cancer	0.000229	0.0529	CrCbGaD
Thioridazine—ADRA1A—adrenal gland—breast cancer	0.000229	0.0158	CbGeAlD
Thioridazine—KCNH2—female reproductive system—breast cancer	0.000226	0.0157	CbGeAlD
Thioridazine—CYP2C8—pituitary gland—breast cancer	0.000226	0.0157	CbGeAlD
Thioridazine—KCNH2—adrenal gland—breast cancer	0.000221	0.0153	CbGeAlD
Thioridazine—HRH1—endometrium—breast cancer	0.000219	0.0152	CbGeAlD
Thioridazine—HTR1A—endocrine gland—breast cancer	0.000215	0.0149	CbGeAlD
Thioridazine—ADRA2A—endometrium—breast cancer	0.000215	0.0149	CbGeAlD
Thioridazine—KCNH2—bone marrow—breast cancer	0.000214	0.0148	CbGeAlD
Thioridazine—CYP2C8—female reproductive system—breast cancer	0.000207	0.0143	CbGeAlD
Thioridazine—KCNH2—female gonad—breast cancer	0.000206	0.0143	CbGeAlD
Thioridazine—HTR7—endocrine gland—breast cancer	0.000206	0.0142	CbGeAlD
Thioridazine—HTR2A—epithelium—breast cancer	0.000204	0.0141	CbGeAlD
Thioridazine—CYP2C19—endocrine gland—breast cancer	0.000201	0.0139	CbGeAlD
Thioridazine—ADRA1A—endocrine gland—breast cancer	0.000198	0.0137	CbGeAlD
Thioridazine—ADRA2A—uterus—breast cancer	0.000198	0.0137	CbGeAlD
Thioridazine—HRH1—adipose tissue—breast cancer	0.000197	0.0137	CbGeAlD
Thioridazine—ADRA2A—pituitary gland—breast cancer	0.000195	0.0135	CbGeAlD
Thioridazine—DRD2—endocrine gland—breast cancer	0.000194	0.0135	CbGeAlD
Thioridazine—Ethopropazine—BCHE—breast cancer	0.000194	0.0448	CrCbGaD
Thioridazine—ADRA2A—adipose tissue—breast cancer	0.000194	0.0134	CbGeAlD
Thioridazine—KCNH2—endocrine gland—breast cancer	0.000191	0.0133	CbGeAlD
Thioridazine—CYP2C9—female reproductive system—breast cancer	0.000184	0.0127	CbGeAlD
Thioridazine—HRH1—female reproductive system—breast cancer	0.000181	0.0126	CbGeAlD
Thioridazine—ADRA2A—female reproductive system—breast cancer	0.000178	0.0123	CbGeAlD
Thioridazine—HRH1—adrenal gland—breast cancer	0.000177	0.0123	CbGeAlD
Thioridazine—CYP2C8—endocrine gland—breast cancer	0.000175	0.0121	CbGeAlD
Thioridazine—CYP2E1—female reproductive system—breast cancer	0.000174	0.0121	CbGeAlD
Thioridazine—ADRA2A—adrenal gland—breast cancer	0.000174	0.012	CbGeAlD
Thioridazine—Clemastine—CYP2D6—breast cancer	0.00017	0.0393	CrCbGaD
Thioridazine—CYP2E1—adrenal gland—breast cancer	0.00017	0.0118	CbGeAlD
Thioridazine—Eletriptan—PTGS1—breast cancer	0.000169	0.039	CrCbGaD
Thioridazine—HTR2A—pituitary gland—breast cancer	0.000165	0.0115	CbGeAlD
Thioridazine—HRH1—female gonad—breast cancer	0.000165	0.0114	CbGeAlD
Thioridazine—CYP1A2—endocrine gland—breast cancer	0.000164	0.0113	CbGeAlD
Thioridazine—Clomipramine—GSTP1—breast cancer	0.000163	0.0376	CrCbGaD
Thioridazine—ADRA2A—female gonad—breast cancer	0.000162	0.0112	CbGeAlD
Thioridazine—Triflupromazine—BCHE—breast cancer	0.000159	0.0367	CrCbGaD
Thioridazine—CYP2C9—endocrine gland—breast cancer	0.000156	0.0108	CbGeAlD
Thioridazine—HRH1—endocrine gland—breast cancer	0.000153	0.0106	CbGeAlD
Thioridazine—HTR2A—female reproductive system—breast cancer	0.000151	0.0105	CbGeAlD
Thioridazine—ADRA2A—endocrine gland—breast cancer	0.000151	0.0104	CbGeAlD
Thioridazine—HTR2A—adrenal gland—breast cancer	0.000148	0.0102	CbGeAlD
Thioridazine—CYP2E1—endocrine gland—breast cancer	0.000147	0.0102	CbGeAlD
Thioridazine—Clemastine—CYP3A4—breast cancer	0.000146	0.0338	CrCbGaD
Thioridazine—CYP2D6—female reproductive system—breast cancer	0.000138	0.00955	CbGeAlD
Thioridazine—KCNH2—lymph node—breast cancer	0.000132	0.00916	CbGeAlD
Thioridazine—Agitation—Paclitaxel—breast cancer	0.000131	0.000758	CcSEcCtD
Thioridazine—Body temperature increased—Thiotepa—breast cancer	0.000131	0.000756	CcSEcCtD
Thioridazine—Headache—Vinblastine—breast cancer	0.00013	0.000755	CcSEcCtD
Thioridazine—Angioedema—Paclitaxel—breast cancer	0.00013	0.000754	CcSEcCtD
Thioridazine—Anorexia—Fluorouracil—breast cancer	0.00013	0.000754	CcSEcCtD
Thioridazine—Hypotension—Gemcitabine—breast cancer	0.00013	0.000752	CcSEcCtD
Thioridazine—Cardiac arrest—Epirubicin—breast cancer	0.000129	0.000745	CcSEcCtD
Thioridazine—Vomiting—Tamoxifen—breast cancer	0.000129	0.000744	CcSEcCtD
Thioridazine—HTR2A—endocrine gland—breast cancer	0.000128	0.00887	CbGeAlD
Thioridazine—Lethargy—Doxorubicin—breast cancer	0.000128	0.00074	CcSEcCtD
Thioridazine—Hypotension—Fluorouracil—breast cancer	0.000128	0.000739	CcSEcCtD
Thioridazine—Leukopenia—Paclitaxel—breast cancer	0.000128	0.000739	CcSEcCtD
Thioridazine—Rash—Tamoxifen—breast cancer	0.000128	0.000738	CcSEcCtD
Thioridazine—Hypersensitivity—Vinorelbine—breast cancer	0.000128	0.000738	CcSEcCtD
Thioridazine—Dermatitis—Tamoxifen—breast cancer	0.000127	0.000737	CcSEcCtD
Thioridazine—Somnolence—Irinotecan—breast cancer	0.000127	0.000734	CcSEcCtD
Thioridazine—Somnolence—Mitoxantrone—breast cancer	0.000127	0.000734	CcSEcCtD
Thioridazine—Headache—Tamoxifen—breast cancer	0.000127	0.000733	CcSEcCtD
Thioridazine—Vomiting—Melphalan—breast cancer	0.000126	0.000729	CcSEcCtD
Thioridazine—CYP2D6—female gonad—breast cancer	0.000126	0.00869	CbGeAlD
Thioridazine—Asthma—Methotrexate—breast cancer	0.000125	0.000724	CcSEcCtD
Thioridazine—Rash—Melphalan—breast cancer	0.000125	0.000723	CcSEcCtD
Thioridazine—Dermatitis—Melphalan—breast cancer	0.000125	0.000722	CcSEcCtD
Thioridazine—Decreased appetite—Mitoxantrone—breast cancer	0.000124	0.000718	CcSEcCtD
Thioridazine—Decreased appetite—Irinotecan—breast cancer	0.000124	0.000718	CcSEcCtD
Thioridazine—Arrhythmia—Docetaxel—breast cancer	0.000124	0.000718	CcSEcCtD
Thioridazine—Eosinophilia—Methotrexate—breast cancer	0.000124	0.000716	CcSEcCtD
Thioridazine—Nausea—Vinblastine—breast cancer	0.000124	0.000716	CcSEcCtD
Thioridazine—Somnolence—Gemcitabine—breast cancer	0.000124	0.000715	CcSEcCtD
Thioridazine—Vomiting—Goserelin—breast cancer	0.000123	0.000711	CcSEcCtD
Thioridazine—Constipation—Mitoxantrone—breast cancer	0.000122	0.000706	CcSEcCtD
Thioridazine—Constipation—Irinotecan—breast cancer	0.000122	0.000706	CcSEcCtD
Thioridazine—Rash—Goserelin—breast cancer	0.000122	0.000705	CcSEcCtD
Thioridazine—Hypersensitivity—Thiotepa—breast cancer	0.000122	0.000705	CcSEcCtD
Thioridazine—Dermatitis—Goserelin—breast cancer	0.000122	0.000704	CcSEcCtD
Thioridazine—Mental disorder—Docetaxel—breast cancer	0.000122	0.000704	CcSEcCtD
Thioridazine—Somnolence—Fluorouracil—breast cancer	0.000122	0.000703	CcSEcCtD
Thioridazine—Headache—Goserelin—breast cancer	0.000121	0.0007	CcSEcCtD
Thioridazine—Erythema—Docetaxel—breast cancer	0.000121	0.000699	CcSEcCtD
Thioridazine—Decreased appetite—Gemcitabine—breast cancer	0.000121	0.000699	CcSEcCtD
Thioridazine—Nausea—Tamoxifen—breast cancer	0.00012	0.000695	CcSEcCtD
Thioridazine—Arrhythmia—Capecitabine—breast cancer	0.00012	0.000695	CcSEcCtD
Thioridazine—Cardiac arrest—Doxorubicin—breast cancer	0.000119	0.000689	CcSEcCtD
Thioridazine—Constipation—Gemcitabine—breast cancer	0.000119	0.000688	CcSEcCtD
Thioridazine—Decreased appetite—Fluorouracil—breast cancer	0.000119	0.000688	CcSEcCtD
Thioridazine—Pancytopenia—Methotrexate—breast cancer	0.000119	0.000687	CcSEcCtD
Thioridazine—Diarrhoea—Vinorelbine—breast cancer	0.000118	0.000685	CcSEcCtD
Thioridazine—Mental disorder—Capecitabine—breast cancer	0.000118	0.000682	CcSEcCtD
Thioridazine—Nausea—Melphalan—breast cancer	0.000118	0.000681	CcSEcCtD
Thioridazine—Feeling abnormal—Mitoxantrone—breast cancer	0.000118	0.000681	CcSEcCtD
Thioridazine—Feeling abnormal—Irinotecan—breast cancer	0.000118	0.000681	CcSEcCtD
Thioridazine—Confusional state—Paclitaxel—breast cancer	0.000117	0.000679	CcSEcCtD
Thioridazine—Erythema—Capecitabine—breast cancer	0.000117	0.000677	CcSEcCtD
Thioridazine—Asthma—Epirubicin—breast cancer	0.000117	0.000677	CcSEcCtD
Thioridazine—CYP2D6—endocrine gland—breast cancer	0.000117	0.00808	CbGeAlD
Thioridazine—Oedema—Paclitaxel—breast cancer	0.000116	0.000674	CcSEcCtD
Thioridazine—Eosinophilia—Epirubicin—breast cancer	0.000116	0.00067	CcSEcCtD
Thioridazine—Eletriptan—CYP2D6—breast cancer	0.000115	0.0266	CrCbGaD
Thioridazine—Nausea—Goserelin—breast cancer	0.000115	0.000664	CcSEcCtD
Thioridazine—Feeling abnormal—Gemcitabine—breast cancer	0.000115	0.000663	CcSEcCtD
Thioridazine—Photosensitivity reaction—Methotrexate—breast cancer	0.000114	0.00066	CcSEcCtD
Thioridazine—Thrombocytopenia—Paclitaxel—breast cancer	0.000114	0.000659	CcSEcCtD
Thioridazine—Tachycardia—Paclitaxel—breast cancer	0.000114	0.000657	CcSEcCtD
Thioridazine—Diarrhoea—Thiotepa—breast cancer	0.000113	0.000654	CcSEcCtD
Thioridazine—Body temperature increased—Irinotecan—breast cancer	0.000113	0.000653	CcSEcCtD
Thioridazine—Body temperature increased—Mitoxantrone—breast cancer	0.000113	0.000653	CcSEcCtD
Thioridazine—Feeling abnormal—Fluorouracil—breast cancer	0.000113	0.000652	CcSEcCtD
Thioridazine—Hyperhidrosis—Paclitaxel—breast cancer	0.000113	0.000651	CcSEcCtD
Thioridazine—Anaemia—Docetaxel—breast cancer	0.000112	0.000647	CcSEcCtD
Thioridazine—Drowsiness—Methotrexate—breast cancer	0.000112	0.000645	CcSEcCtD
Thioridazine—Pancytopenia—Epirubicin—breast cancer	0.000111	0.000643	CcSEcCtD
Thioridazine—Anorexia—Paclitaxel—breast cancer	0.000111	0.000642	CcSEcCtD
Thioridazine—Vision blurred—Capecitabine—breast cancer	0.00011	0.000638	CcSEcCtD
Thioridazine—Vomiting—Vinorelbine—breast cancer	0.00011	0.000637	CcSEcCtD
Thioridazine—Body temperature increased—Gemcitabine—breast cancer	0.00011	0.000636	CcSEcCtD
Thioridazine—Tremor—Capecitabine—breast cancer	0.00011	0.000635	CcSEcCtD
Thioridazine—Rash—Vinorelbine—breast cancer	0.000109	0.000631	CcSEcCtD
Thioridazine—Dermatitis—Vinorelbine—breast cancer	0.000109	0.000631	CcSEcCtD
Thioridazine—Mequitazine—CYP2D6—breast cancer	0.000109	0.0252	CrCbGaD
Thioridazine—Hypotension—Paclitaxel—breast cancer	0.000109	0.000629	CcSEcCtD
Thioridazine—Alimemazine—CYP3A4—breast cancer	0.000109	0.0251	CrCbGaD
Thioridazine—Headache—Vinorelbine—breast cancer	0.000108	0.000627	CcSEcCtD
Thioridazine—Asthma—Doxorubicin—breast cancer	0.000108	0.000627	CcSEcCtD
Thioridazine—Leukopenia—Docetaxel—breast cancer	0.000108	0.000626	CcSEcCtD
Thioridazine—Anaemia—Capecitabine—breast cancer	0.000108	0.000626	CcSEcCtD
Thioridazine—Body temperature increased—Fluorouracil—breast cancer	0.000108	0.000625	CcSEcCtD
Thioridazine—Eosinophilia—Doxorubicin—breast cancer	0.000107	0.00062	CcSEcCtD
Thioridazine—Photosensitivity reaction—Epirubicin—breast cancer	0.000107	0.000618	CcSEcCtD
Thioridazine—Weight increased—Epirubicin—breast cancer	0.000107	0.000616	CcSEcCtD
Thioridazine—HRH1—lymph node—breast cancer	0.000106	0.00734	CbGeAlD
Thioridazine—Hypersensitivity—Irinotecan—breast cancer	0.000105	0.000608	CcSEcCtD
Thioridazine—Hypersensitivity—Mitoxantrone—breast cancer	0.000105	0.000608	CcSEcCtD
Thioridazine—Vomiting—Thiotepa—breast cancer	0.000105	0.000608	CcSEcCtD
Thioridazine—Leukopenia—Capecitabine—breast cancer	0.000105	0.000606	CcSEcCtD
Thioridazine—Drowsiness—Epirubicin—breast cancer	0.000104	0.000604	CcSEcCtD
Thioridazine—Rash—Thiotepa—breast cancer	0.000104	0.000603	CcSEcCtD
Thioridazine—ADRA2A—lymph node—breast cancer	0.000104	0.00721	CbGeAlD
Thioridazine—Dermatitis—Thiotepa—breast cancer	0.000104	0.000602	CcSEcCtD
Thioridazine—Agranulocytosis—Methotrexate—breast cancer	0.000104	0.000602	CcSEcCtD
Thioridazine—Headache—Thiotepa—breast cancer	0.000104	0.000599	CcSEcCtD
Thioridazine—Somnolence—Paclitaxel—breast cancer	0.000104	0.000599	CcSEcCtD
Thioridazine—Pancytopenia—Doxorubicin—breast cancer	0.000103	0.000595	CcSEcCtD
Thioridazine—Nausea—Vinorelbine—breast cancer	0.000103	0.000595	CcSEcCtD
Thioridazine—Jaundice—Epirubicin—breast cancer	0.000102	0.000588	CcSEcCtD
Thioridazine—Decreased appetite—Paclitaxel—breast cancer	0.000101	0.000585	CcSEcCtD
Thioridazine—Hypersensitivity—Fluorouracil—breast cancer	0.000101	0.000583	CcSEcCtD
Thioridazine—Constipation—Paclitaxel—breast cancer	9.96e-05	0.000576	CcSEcCtD
Thioridazine—Confusional state—Docetaxel—breast cancer	9.95e-05	0.000576	CcSEcCtD
Thioridazine—Photosensitivity reaction—Doxorubicin—breast cancer	9.89e-05	0.000572	CcSEcCtD
Thioridazine—Oedema—Docetaxel—breast cancer	9.87e-05	0.000571	CcSEcCtD
Thioridazine—Eletriptan—CYP3A4—breast cancer	9.87e-05	0.0228	CrCbGaD
Thioridazine—Weight increased—Doxorubicin—breast cancer	9.86e-05	0.00057	CcSEcCtD
Thioridazine—Nausea—Thiotepa—breast cancer	9.82e-05	0.000568	CcSEcCtD
Thioridazine—Diarrhoea—Mitoxantrone—breast cancer	9.77e-05	0.000565	CcSEcCtD
Thioridazine—Diarrhoea—Irinotecan—breast cancer	9.77e-05	0.000565	CcSEcCtD
Thioridazine—Agranulocytosis—Epirubicin—breast cancer	9.74e-05	0.000563	CcSEcCtD
Thioridazine—Thrombocytopenia—Docetaxel—breast cancer	9.66e-05	0.000559	CcSEcCtD
Thioridazine—Drowsiness—Doxorubicin—breast cancer	9.66e-05	0.000559	CcSEcCtD
Thioridazine—Confusional state—Capecitabine—breast cancer	9.63e-05	0.000557	CcSEcCtD
Thioridazine—Tachycardia—Docetaxel—breast cancer	9.63e-05	0.000557	CcSEcCtD
Thioridazine—Feeling abnormal—Paclitaxel—breast cancer	9.59e-05	0.000555	CcSEcCtD
Thioridazine—Oedema—Capecitabine—breast cancer	9.55e-05	0.000553	CcSEcCtD
Thioridazine—Diarrhoea—Gemcitabine—breast cancer	9.51e-05	0.00055	CcSEcCtD
Thioridazine—Jaundice—Doxorubicin—breast cancer	9.41e-05	0.000545	CcSEcCtD
Thioridazine—Anorexia—Docetaxel—breast cancer	9.41e-05	0.000544	CcSEcCtD
Thioridazine—Diarrhoea—Fluorouracil—breast cancer	9.36e-05	0.000541	CcSEcCtD
Thioridazine—Thrombocytopenia—Capecitabine—breast cancer	9.35e-05	0.000541	CcSEcCtD
Thioridazine—Mequitazine—CYP3A4—breast cancer	9.35e-05	0.0216	CrCbGaD
Thioridazine—Tachycardia—Capecitabine—breast cancer	9.33e-05	0.000539	CcSEcCtD
Thioridazine—Hyperhidrosis—Capecitabine—breast cancer	9.24e-05	0.000534	CcSEcCtD
Thioridazine—Oedema peripheral—Epirubicin—breast cancer	9.23e-05	0.000534	CcSEcCtD
Thioridazine—Hypotension—Docetaxel—breast cancer	9.22e-05	0.000533	CcSEcCtD
Thioridazine—Body temperature increased—Paclitaxel—breast cancer	9.2e-05	0.000532	CcSEcCtD
Thioridazine—Anorexia—Capecitabine—breast cancer	9.11e-05	0.000527	CcSEcCtD
Thioridazine—Vomiting—Mitoxantrone—breast cancer	9.08e-05	0.000525	CcSEcCtD
Thioridazine—Vomiting—Irinotecan—breast cancer	9.08e-05	0.000525	CcSEcCtD
Thioridazine—Agranulocytosis—Doxorubicin—breast cancer	9.01e-05	0.000521	CcSEcCtD
Thioridazine—Rash—Irinotecan—breast cancer	9e-05	0.000521	CcSEcCtD
Thioridazine—Rash—Mitoxantrone—breast cancer	9e-05	0.000521	CcSEcCtD
Thioridazine—Zuclopenthixol—CYP2D6—breast cancer	9e-05	0.0208	CrCbGaD
Thioridazine—Dermatitis—Mitoxantrone—breast cancer	8.99e-05	0.00052	CcSEcCtD
Thioridazine—Dermatitis—Irinotecan—breast cancer	8.99e-05	0.00052	CcSEcCtD
Thioridazine—Headache—Mitoxantrone—breast cancer	8.94e-05	0.000517	CcSEcCtD
Thioridazine—Headache—Irinotecan—breast cancer	8.94e-05	0.000517	CcSEcCtD
Thioridazine—Hypotension—Capecitabine—breast cancer	8.93e-05	0.000516	CcSEcCtD
Thioridazine—Vomiting—Gemcitabine—breast cancer	8.84e-05	0.000511	CcSEcCtD
Thioridazine—Somnolence—Docetaxel—breast cancer	8.77e-05	0.000508	CcSEcCtD
Thioridazine—Mental disorder—Methotrexate—breast cancer	8.77e-05	0.000507	CcSEcCtD
Thioridazine—Rash—Gemcitabine—breast cancer	8.77e-05	0.000507	CcSEcCtD
Thioridazine—Dermatitis—Gemcitabine—breast cancer	8.76e-05	0.000507	CcSEcCtD
Thioridazine—Erythema—Methotrexate—breast cancer	8.72e-05	0.000504	CcSEcCtD
Thioridazine—Headache—Gemcitabine—breast cancer	8.71e-05	0.000504	CcSEcCtD
Thioridazine—Vomiting—Fluorouracil—breast cancer	8.69e-05	0.000503	CcSEcCtD
Thioridazine—Rash—Fluorouracil—breast cancer	8.62e-05	0.000499	CcSEcCtD
Thioridazine—Dermatitis—Fluorouracil—breast cancer	8.61e-05	0.000498	CcSEcCtD
Thioridazine—Decreased appetite—Docetaxel—breast cancer	8.58e-05	0.000496	CcSEcCtD
Thioridazine—Hypersensitivity—Paclitaxel—breast cancer	8.58e-05	0.000496	CcSEcCtD
Thioridazine—Headache—Fluorouracil—breast cancer	8.57e-05	0.000496	CcSEcCtD
Thioridazine—Oedema peripheral—Doxorubicin—breast cancer	8.54e-05	0.000494	CcSEcCtD
Thioridazine—Nausea—Mitoxantrone—breast cancer	8.48e-05	0.000491	CcSEcCtD
Thioridazine—Nausea—Irinotecan—breast cancer	8.48e-05	0.000491	CcSEcCtD
Thioridazine—Constipation—Docetaxel—breast cancer	8.44e-05	0.000488	CcSEcCtD
Thioridazine—Arrhythmia—Epirubicin—breast cancer	8.37e-05	0.000484	CcSEcCtD
Thioridazine—Decreased appetite—Capecitabine—breast cancer	8.31e-05	0.00048	CcSEcCtD
Thioridazine—Nausea—Gemcitabine—breast cancer	8.26e-05	0.000478	CcSEcCtD
Thioridazine—Vision blurred—Methotrexate—breast cancer	8.21e-05	0.000475	CcSEcCtD
Thioridazine—Eletriptan—ABCB1—breast cancer	8.21e-05	0.019	CrCbGaD
Thioridazine—Mental disorder—Epirubicin—breast cancer	8.21e-05	0.000475	CcSEcCtD
Thioridazine—Constipation—Capecitabine—breast cancer	8.17e-05	0.000473	CcSEcCtD
Thioridazine—Erythema—Epirubicin—breast cancer	8.16e-05	0.000472	CcSEcCtD
Thioridazine—Feeling abnormal—Docetaxel—breast cancer	8.13e-05	0.00047	CcSEcCtD
Thioridazine—Nausea—Fluorouracil—breast cancer	8.12e-05	0.00047	CcSEcCtD
Thioridazine—Anaemia—Methotrexate—breast cancer	8.06e-05	0.000466	CcSEcCtD
Thioridazine—Diarrhoea—Paclitaxel—breast cancer	7.97e-05	0.000461	CcSEcCtD
Thioridazine—Feeling abnormal—Capecitabine—breast cancer	7.87e-05	0.000455	CcSEcCtD
Thioridazine—Body temperature increased—Docetaxel—breast cancer	7.8e-05	0.000451	CcSEcCtD
Thioridazine—Leukopenia—Methotrexate—breast cancer	7.8e-05	0.000451	CcSEcCtD
Thioridazine—Thiothixene—CYP2D6—breast cancer	7.76e-05	0.0179	CrCbGaD
Thioridazine—Pipotiazine—CYP2D6—breast cancer	7.76e-05	0.0179	CrCbGaD
Thioridazine—Arrhythmia—Doxorubicin—breast cancer	7.74e-05	0.000448	CcSEcCtD
Thioridazine—Vision blurred—Epirubicin—breast cancer	7.69e-05	0.000445	CcSEcCtD
Thioridazine—Chlorpromazine—BCHE—breast cancer	7.66e-05	0.0177	CrCbGaD
Thioridazine—Mesoridazine—CYP2D6—breast cancer	7.65e-05	0.0177	CrCbGaD
Thioridazine—Mental disorder—Doxorubicin—breast cancer	7.59e-05	0.000439	CcSEcCtD
Thioridazine—Body temperature increased—Capecitabine—breast cancer	7.55e-05	0.000437	CcSEcCtD
Thioridazine—Erythema—Doxorubicin—breast cancer	7.55e-05	0.000437	CcSEcCtD
Thioridazine—Anaemia—Epirubicin—breast cancer	7.54e-05	0.000436	CcSEcCtD
Thioridazine—Agitation—Epirubicin—breast cancer	7.49e-05	0.000434	CcSEcCtD
Thioridazine—Prochlorperazine—CYP2D6—breast cancer	7.41e-05	0.0171	CrCbGaD
Thioridazine—Vomiting—Paclitaxel—breast cancer	7.4e-05	0.000428	CcSEcCtD
Thioridazine—Rash—Paclitaxel—breast cancer	7.34e-05	0.000425	CcSEcCtD
Thioridazine—Dermatitis—Paclitaxel—breast cancer	7.33e-05	0.000424	CcSEcCtD
Thioridazine—Leukopenia—Epirubicin—breast cancer	7.3e-05	0.000422	CcSEcCtD
Thioridazine—Headache—Paclitaxel—breast cancer	7.29e-05	0.000422	CcSEcCtD
Thioridazine—Hypersensitivity—Docetaxel—breast cancer	7.27e-05	0.000421	CcSEcCtD
Thioridazine—Confusional state—Methotrexate—breast cancer	7.17e-05	0.000415	CcSEcCtD
Thioridazine—Vision blurred—Doxorubicin—breast cancer	7.11e-05	0.000411	CcSEcCtD
Thioridazine—Hypersensitivity—Capecitabine—breast cancer	7.04e-05	0.000407	CcSEcCtD
Thioridazine—Anaemia—Doxorubicin—breast cancer	6.97e-05	0.000403	CcSEcCtD
Thioridazine—Thrombocytopenia—Methotrexate—breast cancer	6.96e-05	0.000403	CcSEcCtD
Thioridazine—Agitation—Doxorubicin—breast cancer	6.93e-05	0.000401	CcSEcCtD
Thioridazine—Nausea—Paclitaxel—breast cancer	6.92e-05	0.0004	CcSEcCtD
Thioridazine—Hyperhidrosis—Methotrexate—breast cancer	6.88e-05	0.000398	CcSEcCtD
Thioridazine—Anorexia—Methotrexate—breast cancer	6.78e-05	0.000392	CcSEcCtD
Thioridazine—Leukopenia—Doxorubicin—breast cancer	6.75e-05	0.000391	CcSEcCtD
Thioridazine—Diarrhoea—Docetaxel—breast cancer	6.75e-05	0.000391	CcSEcCtD
Thioridazine—Confusional state—Epirubicin—breast cancer	6.71e-05	0.000388	CcSEcCtD
Thioridazine—Fluphenazine—CYP2D6—breast cancer	6.7e-05	0.0155	CrCbGaD
Thioridazine—Oedema—Epirubicin—breast cancer	6.66e-05	0.000385	CcSEcCtD
Thioridazine—Pipotiazine—CYP3A4—breast cancer	6.65e-05	0.0154	CrCbGaD
Thioridazine—Hypotension—Methotrexate—breast cancer	6.65e-05	0.000384	CcSEcCtD
Thioridazine—Diarrhoea—Capecitabine—breast cancer	6.54e-05	0.000378	CcSEcCtD
Thioridazine—Thrombocytopenia—Epirubicin—breast cancer	6.52e-05	0.000377	CcSEcCtD
Thioridazine—Tachycardia—Epirubicin—breast cancer	6.5e-05	0.000376	CcSEcCtD
Thioridazine—Hyperhidrosis—Epirubicin—breast cancer	6.43e-05	0.000372	CcSEcCtD
Thioridazine—Prochlorperazine—CYP3A4—breast cancer	6.36e-05	0.0147	CrCbGaD
Thioridazine—Anorexia—Epirubicin—breast cancer	6.34e-05	0.000367	CcSEcCtD
Thioridazine—Somnolence—Methotrexate—breast cancer	6.32e-05	0.000366	CcSEcCtD
Thioridazine—Vomiting—Docetaxel—breast cancer	6.27e-05	0.000363	CcSEcCtD
Thioridazine—Triflupromazine—ABCB1—breast cancer	6.22e-05	0.0144	CrCbGaD
Thioridazine—Rash—Docetaxel—breast cancer	6.22e-05	0.00036	CcSEcCtD
Thioridazine—Hypotension—Epirubicin—breast cancer	6.22e-05	0.00036	CcSEcCtD
Thioridazine—Dermatitis—Docetaxel—breast cancer	6.22e-05	0.00036	CcSEcCtD
Thioridazine—Confusional state—Doxorubicin—breast cancer	6.21e-05	0.000359	CcSEcCtD
Thioridazine—Decreased appetite—Methotrexate—breast cancer	6.18e-05	0.000358	CcSEcCtD
Thioridazine—Headache—Docetaxel—breast cancer	6.18e-05	0.000358	CcSEcCtD
Thioridazine—Oedema—Doxorubicin—breast cancer	6.16e-05	0.000356	CcSEcCtD
Thioridazine—Clomipramine—CYP2D6—breast cancer	6.13e-05	0.0142	CrCbGaD
Thioridazine—Vomiting—Capecitabine—breast cancer	6.07e-05	0.000351	CcSEcCtD
Thioridazine—Acepromazine—ALB—breast cancer	6.03e-05	0.0139	CrCbGaD
Thioridazine—Thrombocytopenia—Doxorubicin—breast cancer	6.03e-05	0.000349	CcSEcCtD
Thioridazine—Rash—Capecitabine—breast cancer	6.02e-05	0.000348	CcSEcCtD
Thioridazine—Dermatitis—Capecitabine—breast cancer	6.02e-05	0.000348	CcSEcCtD
Thioridazine—Tachycardia—Doxorubicin—breast cancer	6.01e-05	0.000348	CcSEcCtD
Thioridazine—Headache—Capecitabine—breast cancer	5.99e-05	0.000346	CcSEcCtD
Thioridazine—Hyperhidrosis—Doxorubicin—breast cancer	5.95e-05	0.000344	CcSEcCtD
Thioridazine—Somnolence—Epirubicin—breast cancer	5.92e-05	0.000342	CcSEcCtD
Thioridazine—Thioproperazine—ALB—breast cancer	5.9e-05	0.0136	CrCbGaD
Thioridazine—Anorexia—Doxorubicin—breast cancer	5.87e-05	0.00034	CcSEcCtD
Thioridazine—Nausea—Docetaxel—breast cancer	5.86e-05	0.000339	CcSEcCtD
Thioridazine—Feeling abnormal—Methotrexate—breast cancer	5.86e-05	0.000339	CcSEcCtD
Thioridazine—Pipotiazine—ALB—breast cancer	5.8e-05	0.0134	CrCbGaD
Thioridazine—Thiothixene—ALB—breast cancer	5.8e-05	0.0134	CrCbGaD
Thioridazine—Decreased appetite—Epirubicin—breast cancer	5.79e-05	0.000335	CcSEcCtD
Thioridazine—Hypotension—Doxorubicin—breast cancer	5.76e-05	0.000333	CcSEcCtD
Thioridazine—Constipation—Epirubicin—breast cancer	5.69e-05	0.000329	CcSEcCtD
Thioridazine—Nausea—Capecitabine—breast cancer	5.68e-05	0.000328	CcSEcCtD
Thioridazine—Body temperature increased—Methotrexate—breast cancer	5.62e-05	0.000325	CcSEcCtD
Thioridazine—Methotrimeprazine—CYP2D6—breast cancer	5.51e-05	0.0127	CrCbGaD
Thioridazine—Feeling abnormal—Epirubicin—breast cancer	5.49e-05	0.000317	CcSEcCtD
Thioridazine—Somnolence—Doxorubicin—breast cancer	5.48e-05	0.000317	CcSEcCtD
Thioridazine—Promethazine—CYP2D6—breast cancer	5.43e-05	0.0126	CrCbGaD
Thioridazine—Decreased appetite—Doxorubicin—breast cancer	5.35e-05	0.00031	CcSEcCtD
Thioridazine—Perphenazine—CYP2D6—breast cancer	5.3e-05	0.0122	CrCbGaD
Thioridazine—Constipation—Doxorubicin—breast cancer	5.27e-05	0.000305	CcSEcCtD
Thioridazine—Body temperature increased—Epirubicin—breast cancer	5.26e-05	0.000304	CcSEcCtD
Thioridazine—Clomipramine—CYP3A4—breast cancer	5.26e-05	0.0122	CrCbGaD
Thioridazine—Hypersensitivity—Methotrexate—breast cancer	5.24e-05	0.000303	CcSEcCtD
Thioridazine—Feeling abnormal—Doxorubicin—breast cancer	5.08e-05	0.000294	CcSEcCtD
Thioridazine—Hypersensitivity—Epirubicin—breast cancer	4.9e-05	0.000284	CcSEcCtD
Thioridazine—Body temperature increased—Doxorubicin—breast cancer	4.87e-05	0.000282	CcSEcCtD
Thioridazine—Diarrhoea—Methotrexate—breast cancer	4.87e-05	0.000282	CcSEcCtD
Thioridazine—Fluphenazine—ABCB1—breast cancer	4.79e-05	0.0111	CrCbGaD
Thioridazine—Clomipramine—ALB—breast cancer	4.59e-05	0.0106	CrCbGaD
Thioridazine—Diarrhoea—Epirubicin—breast cancer	4.55e-05	0.000263	CcSEcCtD
Thioridazine—Perphenazine—CYP3A4—breast cancer	4.55e-05	0.0105	CrCbGaD
Thioridazine—Hypersensitivity—Doxorubicin—breast cancer	4.54e-05	0.000262	CcSEcCtD
Thioridazine—Vomiting—Methotrexate—breast cancer	4.52e-05	0.000262	CcSEcCtD
Thioridazine—Rash—Methotrexate—breast cancer	4.48e-05	0.000259	CcSEcCtD
Thioridazine—Dermatitis—Methotrexate—breast cancer	4.48e-05	0.000259	CcSEcCtD
Thioridazine—Headache—Methotrexate—breast cancer	4.46e-05	0.000258	CcSEcCtD
Thioridazine—Clomipramine—ABCB1—breast cancer	4.38e-05	0.0101	CrCbGaD
Thioridazine—Vomiting—Epirubicin—breast cancer	4.23e-05	0.000245	CcSEcCtD
Thioridazine—Nausea—Methotrexate—breast cancer	4.22e-05	0.000244	CcSEcCtD
Thioridazine—Diarrhoea—Doxorubicin—breast cancer	4.21e-05	0.000244	CcSEcCtD
Thioridazine—Chlorpromazine—CYP2D6—breast cancer	4.2e-05	0.00972	CrCbGaD
Thioridazine—Rash—Epirubicin—breast cancer	4.2e-05	0.000243	CcSEcCtD
Thioridazine—Dermatitis—Epirubicin—breast cancer	4.19e-05	0.000243	CcSEcCtD
Thioridazine—Headache—Epirubicin—breast cancer	4.17e-05	0.000241	CcSEcCtD
Thioridazine—Promazine—CYP3A4—breast cancer	4.1e-05	0.00947	CrCbGaD
Thioridazine—Nausea—Epirubicin—breast cancer	3.95e-05	0.000229	CcSEcCtD
Thioridazine—Vomiting—Doxorubicin—breast cancer	3.92e-05	0.000227	CcSEcCtD
Thioridazine—Rash—Doxorubicin—breast cancer	3.88e-05	0.000225	CcSEcCtD
Thioridazine—Dermatitis—Doxorubicin—breast cancer	3.88e-05	0.000224	CcSEcCtD
Thioridazine—Promethazine—ABCB1—breast cancer	3.88e-05	0.00896	CrCbGaD
Thioridazine—Headache—Doxorubicin—breast cancer	3.86e-05	0.000223	CcSEcCtD
Thioridazine—Trifluoperazine—ABCB1—breast cancer	3.83e-05	0.00884	CrCbGaD
Thioridazine—Nausea—Doxorubicin—breast cancer	3.66e-05	0.000212	CcSEcCtD
Thioridazine—Chlorpromazine—CYP3A4—breast cancer	3.61e-05	0.00833	CrCbGaD
Thioridazine—Chlorpromazine—ALB—breast cancer	3.15e-05	0.00727	CrCbGaD
Thioridazine—Chlorpromazine—ABCB1—breast cancer	3e-05	0.00694	CrCbGaD
Thioridazine—HTR2C—Signaling Pathways—SRC—breast cancer	2.21e-06	1.75e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—TP53—breast cancer	2.21e-06	1.75e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—ERBB2—breast cancer	2.21e-06	1.75e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CDKN1B—breast cancer	2.21e-06	1.75e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—TP53—breast cancer	2.21e-06	1.74e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CASP3—breast cancer	2.2e-06	1.74e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CDKN1B—breast cancer	2.2e-06	1.74e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—IL2—breast cancer	2.2e-06	1.74e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CASP3—breast cancer	2.2e-06	1.74e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PIK3CG—breast cancer	2.2e-06	1.74e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—IL2—breast cancer	2.2e-06	1.74e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—IL6—breast cancer	2.19e-06	1.73e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—IL6—breast cancer	2.19e-06	1.73e-05	CbGpPWpGaD
Thioridazine—CHRM2—GPCR downstream signaling—AKT1—breast cancer	2.18e-06	1.73e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—CCND1—breast cancer	2.18e-06	1.72e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—MTOR—breast cancer	2.18e-06	1.72e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—PIK3CB—breast cancer	2.18e-06	1.72e-05	CbGpPWpGaD
Thioridazine—ADRA1A—GPCR downstream signaling—AKT1—breast cancer	2.18e-06	1.72e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—JUN—breast cancer	2.18e-06	1.72e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—VEGFA—breast cancer	2.17e-06	1.71e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CASP3—breast cancer	2.16e-06	1.71e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—IL2—breast cancer	2.16e-06	1.71e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—CTNNB1—breast cancer	2.16e-06	1.71e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CASP3—breast cancer	2.16e-06	1.71e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—IL2—breast cancer	2.16e-06	1.7e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—VEGFA—breast cancer	2.15e-06	1.7e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—IL6—breast cancer	2.15e-06	1.7e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CCND1—breast cancer	2.15e-06	1.7e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—IL6—breast cancer	2.14e-06	1.69e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—STAT3—breast cancer	2.14e-06	1.69e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—JUN—breast cancer	2.14e-06	1.69e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CCND1—breast cancer	2.14e-06	1.69e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—KRAS—breast cancer	2.14e-06	1.69e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—JUN—breast cancer	2.14e-06	1.69e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—STAT3—breast cancer	2.13e-06	1.69e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CTNNB1—breast cancer	2.13e-06	1.68e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CTNNB1—breast cancer	2.12e-06	1.68e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PIK3CD—breast cancer	2.12e-06	1.68e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—SRC—breast cancer	2.12e-06	1.67e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—MMP9—breast cancer	2.12e-06	1.67e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—HRAS—breast cancer	2.11e-06	1.67e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—HRAS—breast cancer	2.11e-06	1.67e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—CDKN1A—breast cancer	2.11e-06	1.67e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CCND1—breast cancer	2.11e-06	1.67e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—PTEN—breast cancer	2.11e-06	1.66e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—JUN—breast cancer	2.1e-06	1.66e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CCND1—breast cancer	2.1e-06	1.66e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—JUN—breast cancer	2.1e-06	1.66e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CXCL8—breast cancer	2.1e-06	1.66e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—ALB—breast cancer	2.09e-06	1.65e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CTNNB1—breast cancer	2.09e-06	1.65e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—MMP9—breast cancer	2.08e-06	1.65e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—HRAS—breast cancer	2.08e-06	1.65e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CTNNB1—breast cancer	2.08e-06	1.64e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—MMP9—breast cancer	2.08e-06	1.64e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CDKN1A—breast cancer	2.08e-06	1.64e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CDKN1A—breast cancer	2.07e-06	1.64e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—PTEN—breast cancer	2.07e-06	1.64e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—PIK3CB—breast cancer	2.07e-06	1.64e-05	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—PTEN—breast cancer	2.07e-06	1.64e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—PTEN—breast cancer	2.07e-06	1.63e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—CAV1—breast cancer	2.06e-06	1.63e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—VEGFA—breast cancer	2.06e-06	1.63e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—MAPK8—breast cancer	2.06e-06	1.63e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—AKT1—breast cancer	2.05e-06	1.62e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—PTGS2—breast cancer	2.05e-06	1.62e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—MAPK3—breast cancer	2.05e-06	1.62e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CDKN1B—breast cancer	2.05e-06	1.62e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—MMP9—breast cancer	2.05e-06	1.62e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—STAT3—breast cancer	2.04e-06	1.61e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—MMP9—breast cancer	2.04e-06	1.61e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CDKN1A—breast cancer	2.04e-06	1.61e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—MAPK3—breast cancer	2.04e-06	1.61e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—PTEN—breast cancer	2.03e-06	1.61e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CDKN1A—breast cancer	2.03e-06	1.61e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—PTEN—breast cancer	2.03e-06	1.6e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—MAPK8—breast cancer	2.03e-06	1.6e-05	CbGpPWpGaD
Thioridazine—ADRA2A—GPCR downstream signaling—AKT1—breast cancer	2.02e-06	1.6e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—IL6—breast cancer	2.02e-06	1.6e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—MAPK8—breast cancer	2.02e-06	1.6e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—IL6—breast cancer	2.02e-06	1.6e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—AKT1—breast cancer	2.02e-06	1.6e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—AKT1—breast cancer	2.02e-06	1.59e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CASP3—breast cancer	2.01e-06	1.59e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—IL2—breast cancer	2e-06	1.58e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—NOS3—breast cancer	2e-06	1.58e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—IL6—breast cancer	1.99e-06	1.57e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—MYC—breast cancer	1.99e-06	1.57e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—MAPK8—breast cancer	1.99e-06	1.57e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—TGFB1—breast cancer	1.99e-06	1.57e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—AKT1—breast cancer	1.98e-06	1.57e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—MAPK8—breast cancer	1.98e-06	1.57e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—MYC—breast cancer	1.98e-06	1.57e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—AKT1—breast cancer	1.98e-06	1.56e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—TGFB1—breast cancer	1.98e-06	1.56e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.97e-06	1.56e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—PIK3CA—breast cancer	1.97e-06	1.55e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CCND1—breast cancer	1.95e-06	1.54e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—SRC—breast cancer	1.95e-06	1.54e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—MAPK3—breast cancer	1.95e-06	1.54e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PIK3CD—breast cancer	1.95e-06	1.54e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—EGFR—breast cancer	1.95e-06	1.54e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—JUN—breast cancer	1.95e-06	1.54e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—EGFR—breast cancer	1.94e-06	1.53e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CTNNB1—breast cancer	1.93e-06	1.53e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PIK3CD—breast cancer	1.93e-06	1.53e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—ALB—breast cancer	1.92e-06	1.52e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—SRC—breast cancer	1.92e-06	1.52e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—SRC—breast cancer	1.92e-06	1.51e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—ALB—breast cancer	1.91e-06	1.51e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—TP53—breast cancer	1.9e-06	1.5e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—VEGFA—breast cancer	1.9e-06	1.5e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—MYC—breast cancer	1.9e-06	1.5e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—MMP9—breast cancer	1.9e-06	1.5e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—TGFB1—breast cancer	1.89e-06	1.5e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CDKN1A—breast cancer	1.89e-06	1.49e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—SRC—breast cancer	1.89e-06	1.49e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—PTEN—breast cancer	1.88e-06	1.49e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—STAT3—breast cancer	1.88e-06	1.49e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—SRC—breast cancer	1.88e-06	1.49e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PIK3CG—breast cancer	1.88e-06	1.48e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—VEGFA—breast cancer	1.87e-06	1.48e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—VEGFA—breast cancer	1.87e-06	1.48e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—AKT1—breast cancer	1.87e-06	1.48e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—AKT1—breast cancer	1.86e-06	1.47e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—EGFR—breast cancer	1.86e-06	1.47e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—STAT3—breast cancer	1.85e-06	1.46e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—STAT3—breast cancer	1.85e-06	1.46e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PIK3CB—breast cancer	1.85e-06	1.46e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—MAPK8—breast cancer	1.84e-06	1.46e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—NOS3—breast cancer	1.84e-06	1.45e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—KRAS—breast cancer	1.84e-06	1.45e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—AKT1—breast cancer	1.84e-06	1.45e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—VEGFA—breast cancer	1.84e-06	1.45e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—VEGFA—breast cancer	1.83e-06	1.45e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—KRAS—breast cancer	1.83e-06	1.45e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PTGS2—breast cancer	1.83e-06	1.45e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—NOS3—breast cancer	1.83e-06	1.44e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—HRAS—breast cancer	1.82e-06	1.44e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—STAT3—breast cancer	1.82e-06	1.44e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—STAT3—breast cancer	1.81e-06	1.43e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—MAPK3—breast cancer	1.8e-06	1.42e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—PTEN—breast cancer	1.79e-06	1.41e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—MAPK3—breast cancer	1.77e-06	1.4e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—MAPK3—breast cancer	1.77e-06	1.4e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—KRAS—breast cancer	1.75e-06	1.39e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—MYC—breast cancer	1.75e-06	1.38e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—SRC—breast cancer	1.75e-06	1.38e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—TGFB1—breast cancer	1.75e-06	1.38e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—IL6—breast cancer	1.74e-06	1.38e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—MAPK3—breast cancer	1.74e-06	1.37e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—MAPK3—breast cancer	1.73e-06	1.37e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—MYC—breast cancer	1.72e-06	1.36e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—MYC—breast cancer	1.72e-06	1.36e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—TGFB1—breast cancer	1.72e-06	1.36e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—TGFB1—breast cancer	1.71e-06	1.35e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—EGFR—breast cancer	1.71e-06	1.35e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—VEGFA—breast cancer	1.7e-06	1.35e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PIK3CB—breast cancer	1.7e-06	1.34e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—PIK3CA—breast cancer	1.69e-06	1.34e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—MYC—breast cancer	1.69e-06	1.34e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—TGFB1—breast cancer	1.69e-06	1.33e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—MYC—breast cancer	1.69e-06	1.33e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—STAT3—breast cancer	1.69e-06	1.33e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PIK3CB—breast cancer	1.68e-06	1.33e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PTGS2—breast cancer	1.68e-06	1.33e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—EGFR—breast cancer	1.68e-06	1.33e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—PIK3CA—breast cancer	1.68e-06	1.33e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—TGFB1—breast cancer	1.68e-06	1.33e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—EGFR—breast cancer	1.68e-06	1.33e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PTGS2—breast cancer	1.67e-06	1.32e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—EGFR—breast cancer	1.65e-06	1.31e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PIK3CD—breast cancer	1.65e-06	1.31e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—EGFR—breast cancer	1.65e-06	1.3e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—TP53—breast cancer	1.64e-06	1.29e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—ALB—breast cancer	1.63e-06	1.29e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—TP53—breast cancer	1.63e-06	1.29e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—KRAS—breast cancer	1.62e-06	1.28e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—PIK3CA—breast cancer	1.61e-06	1.27e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—MAPK3—breast cancer	1.61e-06	1.27e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—AKT1—breast cancer	1.61e-06	1.27e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PTEN—breast cancer	1.6e-06	1.26e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—KRAS—breast cancer	1.59e-06	1.26e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—PIK3CA—breast cancer	1.59e-06	1.26e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—KRAS—breast cancer	1.59e-06	1.25e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—MYC—breast cancer	1.57e-06	1.24e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—HRAS—breast cancer	1.56e-06	1.24e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—TGFB1—breast cancer	1.56e-06	1.23e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—KRAS—breast cancer	1.56e-06	1.23e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—NOS3—breast cancer	1.56e-06	1.23e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—TP53—breast cancer	1.56e-06	1.23e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—KRAS—breast cancer	1.56e-06	1.23e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—HRAS—breast cancer	1.56e-06	1.23e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—EGFR—breast cancer	1.53e-06	1.21e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—IL6—breast cancer	1.5e-06	1.18e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—HRAS—breast cancer	1.49e-06	1.18e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—IL6—breast cancer	1.49e-06	1.18e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—PIK3CA—breast cancer	1.49e-06	1.17e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PTEN—breast cancer	1.47e-06	1.16e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—PIK3CA—breast cancer	1.46e-06	1.15e-05	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—PIK3CA—breast cancer	1.46e-06	1.15e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—PIK3CA—breast cancer	1.46e-06	1.15e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PTEN—breast cancer	1.46e-06	1.15e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—KRAS—breast cancer	1.45e-06	1.14e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PIK3CB—breast cancer	1.44e-06	1.14e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—TP53—breast cancer	1.44e-06	1.14e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—PIK3CA—breast cancer	1.43e-06	1.13e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—PIK3CA—breast cancer	1.43e-06	1.13e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PTGS2—breast cancer	1.43e-06	1.13e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—IL6—breast cancer	1.43e-06	1.13e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—TP53—breast cancer	1.41e-06	1.12e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—TP53—breast cancer	1.41e-06	1.11e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—TP53—breast cancer	1.39e-06	1.1e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—TP53—breast cancer	1.38e-06	1.09e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—AKT1—breast cancer	1.38e-06	1.09e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—AKT1—breast cancer	1.37e-06	1.09e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—HRAS—breast cancer	1.37e-06	1.09e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—HRAS—breast cancer	1.35e-06	1.07e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—HRAS—breast cancer	1.35e-06	1.07e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—PIK3CA—breast cancer	1.33e-06	1.05e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—HRAS—breast cancer	1.33e-06	1.05e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—HRAS—breast cancer	1.32e-06	1.05e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—AKT1—breast cancer	1.32e-06	1.04e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—IL6—breast cancer	1.32e-06	1.04e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—AKT1—breast cancer	1.3e-06	1.03e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—IL6—breast cancer	1.29e-06	1.02e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—IL6—breast cancer	1.29e-06	1.02e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—TP53—breast cancer	1.29e-06	1.02e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—IL6—breast cancer	1.27e-06	1e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—IL6—breast cancer	1.27e-06	1e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—PIK3CA—breast cancer	1.26e-06	9.97e-06	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PTEN—breast cancer	1.24e-06	9.83e-06	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—HRAS—breast cancer	1.23e-06	9.72e-06	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—AKT1—breast cancer	1.21e-06	9.59e-06	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—AKT1—breast cancer	1.19e-06	9.43e-06	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—AKT1—breast cancer	1.19e-06	9.43e-06	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—AKT1—breast cancer	1.19e-06	9.41e-06	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—IL6—breast cancer	1.18e-06	9.3e-06	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—AKT1—breast cancer	1.17e-06	9.26e-06	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—AKT1—breast cancer	1.17e-06	9.24e-06	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PIK3CA—breast cancer	1.13e-06	8.9e-06	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—AKT1—breast cancer	1.09e-06	8.58e-06	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PIK3CA—breast cancer	1.04e-06	8.19e-06	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—AKT1—breast cancer	1.03e-06	8.15e-06	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PIK3CA—breast cancer	1.03e-06	8.12e-06	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—AKT1—breast cancer	9.2e-07	7.27e-06	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PIK3CA—breast cancer	8.78e-07	6.94e-06	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—AKT1—breast cancer	8.46e-07	6.69e-06	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—AKT1—breast cancer	8.39e-07	6.63e-06	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—AKT1—breast cancer	7.17e-07	5.67e-06	CbGpPWpGaD
